ARCTArcturus Therapeutics Holdings Inc.
7.830USD-0.76%Mkt Cap: 221.13M USDP/E: Last update: 2026-06-01

Arcturus Therapeutics Holdings Inc., a messenger RNA medicines company, focuses on the development of liver and respiratory rare disease therapeutics. Its technology platforms include STARR, a self-amplifying mRNA techno…

Indicators:|

Key Statistics

Company
Market Cap221.13M USD
Enterprise Value37.72M USD
Revenue (TTM)54.71M USD
Gross Profit-44.14M USD
Net Income (TTM)-65.78M USD
Revenue/Share1.974 USD
Last Price7.830 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees106
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-1.98
PEG
EV/EBITDA-0.44
EV/Revenue0.69
P/S4.11
P/B1.18
EPS (TTM)-2.83
EPS (Forward)-3.99
52W Range
5.85011% of range24.17
52W High24.17 USD
52W Low5.850 USD
Profitability
Gross Margin-80.67%
Oper. Margin-1403.74%
EBITDA Margin-156.25%
Profit Margin-97.86%
ROE-30.74%
ROA-24.26%
Growth
Revenue Growth-93.00%
Earnings Growth
Cash Flow & Leverage
Operating CF-74.27M USD
CapEx (TTM)230.00K USD
FCF Margin20.63%
FCF Yield5.11%
Net Debt-187.39M USD
Net Debt/EBITDA2.19
Balance Sheet
Debt/Equity0.12
Current Ratio6.31
Quick Ratio6.19
Book Value/Sh6.733 USD
Cash/Share7.437 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay DateNov 16, 2017
Splits
Last Split1:7
Split DateNov 16, 2017
Analyst Consensus
Rating1.6 (Buy)
Target (Mean)19.89 USD
Target Range8.000 USD40.00 USD
# Analysts9
Ownership
Shares Out.28.42M
Float26.15M
Insiders7.99%
Institutions80.26%
Short Interest
Short Ratio16.0d
Short % Float28.77%
Short % Out.23.13%
Shares Short6.57M
Short (prev mo.)6.25M
Technical
SMA 507.967 (-1.7%)
SMA 20010.54 (-25.7%)
Beta2.42
S&P 52W Chg27.94%
Avg Vol (30d)391.98K
Avg Vol (10d)438.49K
Technical Indicators
RSI (14)50.7
MACD-0.2155
MACD Signal-0.2227
MACD Hist.+0.0072
BB Upper9.516 USD
BB Middle7.928 USD
BB Lower6.341 USD
BB Width40.05%
ATR (14)0.5036 USD
Vol Ratio (20d)0.68x